Prognostic Value of the Multicomponent Improvement (MCI) Endpoint in Patients With Pulmonary Arterial Hypertension (PAH) Treated With Sotatercept

被引：0

作者：

Waxman, A. B. ^{[1
]}

Badesch, D. B. ^{[2
]}

Gibbs, J. S. R. ^{[3
]}

Ghofrani, H. A. ^{[4
,5
]}

Gomberg-Maitland, M. ^{[6
]}

Humbert, M. J. ^{[7
]}

Mclaughlin, V. V. ^{[8
]}

Preston, I. R. ^{[9
]}

Souza, R. ^{[10
]}

Grunig, E. ^{[11
,12
]}

Kope, G. ^{[13
]}

Meyer, G. Bohns ^{[14
]}

Olsson, K. M. ^{[15
]}

Rosenkranz, S. ^{[16
]}

Zhao, Y. ^{[17
]}

Lau, A. ^{[17
]}

Cornell, A. G. ^{[17
]}

Pena, J. ^{[17
]}

Hoeper, M. M. ^{[15
]}

机构：

[1] Brigham & Womans Hosp, Pulm Crit Care Med, Boston, MA USA

[2] Univ Colorado, Med, Aurora, CO USA

[3] Imperial Coll London, Natl Heart & Lung Inst, London, England

[4] Univ Hosp Giessen, Internal Med, Giessen, Germany

[5] Marburg GmbH, Giessen, Germany

[6] GWMFA Heart & Vasc Inst, Cardiol, Washington, DC USA

[7] Hop Bicetre, Pneumol, Le Kremlin Bicetre, France

[8] Univ Michigan Hosp, Ann Arbor, MI USA

[9] Tufts Med Ctr, Pulm Crit Care & Sleep Div, Boston, MA USA

[10] Univ Sao Paulo, Heart Inst, Med Sch, Sao Paulo, Brazil

[11] Thoraxklin Heidelberg, Heidelberg, Germany

[12] German Ctr Lung Res, Heidelberg, Germany

[13] Jagiellonian Univ, Med Coll, John Paul II Hosp, Krakow, Poland

[14] Ctr Hipertensao Pulmonar, Porto Alegre, Brazil

[15] Hannover Med Sch, Hannover, Germany

[16] Univ Hosp Cologne, Cologne, Germany

[17] Merck & Co Inc, Rahway, NJ USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A1014

引用

页数：2

共 50 条

[11] PROGNOSTIC VALUE OF PULMONARY ARTERY DIAMETER IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
Dardi, F.
Saia, F.
Palazzini, M.
Donato, F.
Niro, F.
Guarino, D.
Russo, V.
Taglieri, N.
De Lorenzis, A.
Rotunno, M.
Ballerini, A.
Chietera, F.
Bertozzi, R.
Manes, A.
Lovato, L.
Marrozzini, C.
Galie, N.
CHEST, 2022, 161 (06) : 434A - 434A
[12] Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death
Humbert, Marc
McLaughlin, Vallerie V.
Badesch, David B.
Ghofrani, H. Ardeschir
Gibbs, J. Simon R.
Gomberg-Maitland, Mardi
Preston, Ioana R.
Souza, Rogerio
Waxman, Aaron B.
Moles, Victor M.
Savale, Laurent
Vizza, Carmine Dario
Rosenkranz, Stephan
Shi, Yaru
Miller, Barry
Mackenzie, Harald S.
Kim, Samuel S.
Loureiro, Maria Jose
Patel, Mahesh J.
Koglin, Joerg
Cornell, Alexandra G.
Hoeper, Marius M.
ZENITH Trial Investigators
NEW ENGLAND JOURNAL OF MEDICINE, 2025,
[13] Results of a Planned Analysis of the Effects of Genetic Background on Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)
Montani, D.
Mclaughlin, V. V.
Gibbs, J. S. R.
Gomberg-Maitland, M.
Hoeper, M. M.
Preston, I. R.
Souza, R.
Waxman, A. B.
Subias, P. Escribano
Feldman, J. P.
Meyer, G. Bohns
Olsson, K. M.
Manimaran, S.
Zhao, Y.
Lau, A.
Pena, J.
Badesch, D. B.
Humbert, M. J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
[14] Noninvasive prognostic indicators in treated patients with pulmonary arterial hypertension
Jasiewicz, M.
Skiepko, R.
Knapp, M.
Jasiewicz, P.
Szpakowicz, A.
Sobkowicz, B.
Bodzenta-Lukaszyk, A.
Musial, W. J.
Kaminski, K. A.
EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S228 - S229
[15] Functional Improvement in Pulmonary Arterial Hypertension Patients Treated With Ivabradine
Correale, Michele
Brunetti, Natale Daniele
Montrone, Deodata
Totaro, Antonio
Ferraretti, Armando
Ieva, Riccardo
di Biase, Matteo
JOURNAL OF CARDIAC FAILURE, 2014, 20 (05) : 373 - 375
[16] Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysis
Hoeper, Marius M.
Pausch, Christine
Olsson, Karen M.
Huscher, Doerte
Pittrow, David
Gruenig, Ekkehard
Staehler, Gerd
Vizza, Carmine Dario
Gall, Henning
Distler, Oliver
Opitz, Christian
Gibbs, J. Simon R.
Delcroix, Marion
Ghofrani, H. Ardeschir
Ewert, Ralf
Kaemmerer, Harald
Kabitz, Hans-Joachim
Skowasch, Dirk
Behr, Juergen
Milger, Katrin
Halank, Michael
Wilkens, Heinrike
Seyfarth, Hans-Juergen
Held, Matthias
Dumitrescu, Daniel
Tsangaris, Iraklis
Vonk-Noordegraaf, Anton
Ulrich, Silvia
Klose, Hans
Claussen, Martin
Eisenmann, Stephan
Schmidt, Kai-Helge
Rosenkranz, Stephan
Lange, Tobias J.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (07): : 971 - 981
[17] Impact of Delaying Access to Sotatercept on Patients Living With Pulmonary Arterial Hypertension
Mclaughlin, V. V.
Alsumali, A.
Lui, R.
Martinez, E. C.
Nourhussein, I.
Klok, R.
David, B.
Chevure, J.
Pena, J. de Oliveira
Lautsch, D.
Hoeper, M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
[18] Population health model predicting the long-term impact of sotatercept on morbidity and mortality in patients with Pulmonary Arterial Hypertension (PAH)
Mclaughlin, Vallerie
Alsumali, Adnan
Klok, Rogier
Liu, Rongzhe
Martinez, Eliana
Chevure, Jestinah
Pena, Janethe De Oliveira
Lautsch, Dominik
Hoeper, Marius
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[19] Treatment and survival in patients with pulmonary arterial hypertension (PAH)
Kremers, Hilal Maradit
Slusser, Joshua P.
Scott, Christopher G.
Primatesta, Paola
McGoon, Michael D.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S25 - S25
[20] Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH)
Mclaughlin, Vallerie
Alsumali, Adnan
Liu, Rongzhe
Klok, Rogier
Martinez, Eliana C.
Nourhussein, Iman
Bernotas, David
Chevure, Jestinah
Pausch, Christine
Pena, Janethe De Oliveira
Lautsch, Dominik
Hoeper, Marius M.
ADVANCES IN THERAPY, 2024, 41 (01) : 130 - 151

← 1 2 3 4 5 →